Date | Price Target | Rating | Analyst |
---|---|---|---|
7/19/2024 | Outperform | William Blair | |
5/16/2024 | $35.00 → $49.00 | Neutral → Buy | BofA Securities |
5/8/2023 | $72.00 → $32.00 | Buy → Neutral | BofA Securities |
9/21/2022 | $77.00 | Buy | Jefferies |
8/4/2022 | $80.00 → $69.00 | Overweight → Neutral | Piper Sandler |
2/24/2022 | $129.00 → $118.00 | Neutral → Buy | B of A Securities |
12/8/2021 | $126.00 → $183.00 | Overweight | Piper Sandler |
11/8/2021 | $112.00 → $129.00 | Buy → Neutral | BofA Securities |
10-Q - TRUPANION, INC. (0001371285) (Filer)
8-K - TRUPANION, INC. (0001371285) (Filer)
8-K - TRUPANION, INC. (0001371285) (Filer)
Boehringer Ingelheim, Mars Science & Diagnostics and leading pet, public health and animal health authorities to join Advisory Board Collaboration to address emerging pet and public health threats to protect pets and peopleEarly detection potential has global pet and public health benefits SEATTLE, Aug. 14, 2024 (GLOBE NEWSWIRE) -- Trupanion, Inc. (NASDAQ:TRUP), the leading provider of medical insurance for cats and dogs in North America, in partnership with the Centers for Disease Control and Prevention (CDC), and leading pet industry partners, today announced the formation of a collaborative Advisory Board to launch a Pet & Public Health Early Warning & Detection System. The Advisory B
SEATTLE, May 02, 2024 (GLOBE NEWSWIRE) -- Trupanion, Inc. (NASDAQ:TRUP), a leading provider of medical insurance for cats and dogs, today announced that its Board of Directors has unanimously approved the appointment of Margi Tooth to Chief Executive Officer, effective August 1, 2024. Tooth's appointment to CEO marks the culmination of a multi-year, board-led process. Tooth will also continue as President and hold the dual titles of CEO and President. Additionally, Tooth is anticipated to be appointed to Trupanion's Board of Directors during its July meeting. Trupanion's founder and outgoing CEO Darryl Rawlings will continue to serve in the role of Chair of the Board, in which capacity he
A global entrepreneur with decades of experience growing insurance businesses worldwide, including pet insurance brands in Australia and South AfricaEnthoven associated with Tarmac DLTFM LTD., holder of 8.6% of Trupanion outstanding shares SEATTLE, Nov. 07, 2023 (GLOBE NEWSWIRE) -- Trupanion, Inc. (NASDAQ:TRUP) has appointed Richard Enthoven, Director at PetSure Australia and Hollard Holdings Australia, as an independent director to the Company's Board of Directors, effective today. Tarmac DLTFM LTD. ("Tarmac"), an Enthoven family investment entity, purchased shares of Trupanion in the open market between July and October of 2023, amounting to approximately 8.6% of Trupanion's outsta
4/A - TRUPANION, INC. (0001371285) (Issuer)
4 - TRUPANION, INC. (0001371285) (Issuer)
SEATTLE, Sept. 25, 2024 (GLOBE NEWSWIRE) -- Do you have a Cleocatra? Perhaps a Vampug or Terri-fido. Because whether they're spooky, sweet or somewhere in between—it's time to break out the costume box for Trupanion's Tricked Out for Treats Pet-tacular, a pet costume contest to run throughout October. Starting October 1, Trupanion invites pet parents to share photos of their furry friends in (pet safe!) costumes for a chance to win a custom pet portrait, pet-tacular swag, global spotlight opportunities, and ultimate bragging rights. And with eight tricked-out categories like ‘Solo Stunner' for pet close ups and ‘Clinic Charmer' spotlighting pets and veterinary team members, there's somet
SEATTLE, Sept. 16, 2024 (GLOBE NEWSWIRE) -- Anxiety claims are on the rise, according to Trupanion, Inc. (NASDAQ:TRUP), the leading provider of medical insurance for cats and dogs. Looking at veterinary invoice data from over one million insured pets, Trupanion indicates that in total, and on a per pet basis, 2023 was a record high for the number of veterinary claims related to anxiety and offers tips for pet parents looking for ways to spot or prevent anxiety in their own pets. A Year of Record High Claims for Anxiety In 2023, Trupanion paid 21,180 anxiety claims, and from 2019 - 2023, on average paid about 12,178 anxiety claims per year. These claims have been steadily increasing each
SEATTLE, Sept. 09, 2024 (GLOBE NEWSWIRE) -- Trupanion, Inc. (NASDAQ:TRUP), the leading global provider of medical insurance for cats and dogs, announced today the official launch of its high-quality Trupanion product in Germany and Switzerland. The launch follows the Company's expansion to Continental Europe in 2022 with the acquisition of two rapidly growing pet insurance companies with strong expertise in the region. "We're excited to celebrate this major milestone and offer German and Swiss pet parents and their 29 million pets the unrivaled protection of Trupanion," said Margi Tooth, CEO at Trupanion. "The launch of our Trupanion product in Continental Europe marks a significant step
William Blair initiated coverage of Trupanion with a rating of Outperform
BofA Securities upgraded Trupanion from Neutral to Buy and set a new price target of $49.00 from $35.00 previously
BofA Securities downgraded Trupanion from Buy to Neutral and set a new price target of $32.00 from $72.00 previously
SEATTLE, Aug. 08, 2024 (GLOBE NEWSWIRE) -- Trupanion, Inc. (NASDAQ:TRUP), the leading provider of medical insurance for cats and dogs, today announced financial results for the second quarter ended June 30, 2024. "Q2 was a strong quarter, benefitting from consistent revenue growth and margin expansion," said Margi Tooth, President and Chief Executive Officer of Trupanion. "We were able to once again deliver consistent subscription revenue growth while generating free cash flow of $24 million over the past 12 months. Discretionary profit from our core subscription business increased 63% in the quarter, and we look forward to gradually deploying more capital at high estimated internal rates
SEATTLE, July 18, 2024 (GLOBE NEWSWIRE) -- Trupanion, Inc. (NASDAQ:TRUP), the leader in medical insurance for cats and dogs, announced today it will report financial results for its 2024 second quarter after the market closes on Thursday, August 8, 2024. The company will host a conference call that day beginning shortly after 1:30 p.m. PT / 4:30 p.m. ET. A live webcast, to include a slide presentation, will be available on Trupanion's Investor Relations site under Investor Events at http://investors.trupanion.com and will be archived online for 3 months upon completion of the conference call. Participants can access the conference call by dialing 1-877-300-8521 (United States) or 1-412-3
SEATTLE, May 02, 2024 (GLOBE NEWSWIRE) -- Trupanion, Inc. (NASDAQ:TRUP), the leading provider of medical insurance for cats and dogs, today announced financial results for the first quarter ended March 31, 2024. "It was a solid start to the year, with performance across our key financial metrics as expected," said Margi Tooth, President of Trupanion. "Subscription revenue increased by 22% year-over-year. Moreover, discretionary profit from our core subscription business increased 55% while acquisition spend decreased 23% year-over-year. We continue to prioritize cash flow generation with the intention of gradually increasing our spending on growth as our margins expand." First Quarter
4 - TRUPANION, INC. (0001371285) (Issuer)
4 - TRUPANION, INC. (0001371285) (Issuer)
4 - TRUPANION, INC. (0001371285) (Issuer)
In the last three months, 4 analysts have published ratings on Trupanion (NASDAQ:TRUP), offering a diverse range of perspectives from bullish to bearish. The following table encapsulates their recent ratings, offering a glimpse into the evolving sentiments over the past 30 days and comparing them to the preceding months. Bullish Somewhat Bullish Indifferent Somewhat Bearish Bearish Total Ratings 2 0 2 0 0 Last 30D 0 0 0 0 0 1M Ago 0 0 1 0 0 2M Ago 0 0 0 0 0 3M Ago 2 0 1 0 0 The 12-month price targets assessed by analysts reveal further insights, featuring an average target of $33.75, a high estimate of $49.00, and a low estimate of $22.00. This current average has increas
William Blair analyst Brandon Vazquez initiates coverage on Trupanion (NASDAQ:TRUP) with a Outperform rating.
Investor Ryan Cohen founded Chewy Inc (NYSE:CHWY) back in 2011 as a play on the growing trend of pet supplies and pet health products. New data suggests Cohen may have been early to the trend, with spending on pet supplies and pet insurance seeing a large increase. What Happened: Serving as CEO of Chewy from 2011 to 2018, Cohen put an emphasis on the wide variety of pet products offered to consumers online and providing strong customer service. Cohen sold Chewy to PetSmart in 2017 for $3.35 billion in the largest e-commerce acquisition at the time. The investor may have been early to seeing trends in the pet sector, as a recent Similarweb report shows the pet supply category growing
SC 13G/A - TRUPANION, INC. (0001371285) (Subject)
SC 13G/A - TRUPANION, INC. (0001371285) (Subject)
SC 13G - TRUPANION, INC. (0001371285) (Subject)